NCI's cancer therapy evaluation program: a commitment to treatment trials.
Abrams
Jeffrey S
JS
Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.
Murgo
Anthony
A
Christian
Michaele C
MC
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods* / Q000592:standards*; D006801:Humans; D009316:National Institutes of Health (U.S.) / Q000592:standards / Q000706:statistics & numerical data*; D009369:Neoplasms / Q000628:therapy*; D012107:Research Design / Q000592:standards*; D014481:United States
D000970:Antineoplastic Agents